Age Related Macular Degeneration is a common eye disease that is the leading cause of vision loss in people aged 50 years and older. It causes damage to the macula, a small spot near the center of the retina and a part of the eye needed for sharp central vision, allowing us to see the object in front of it. Age Related Macular Degeneration Drug refers to the drugs used to treat Age Related Macular Degeneration.
This report elaborates the market size, market characteristics, and market growth of the Age Related Macular Degeneration Biologic Drug industry, and breaks down according to the type, application, and consumption area of Age Related Macular Degeneration Biologic Drug. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Age Related Macular Degeneration Biologic Drug in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Age Related Macular Degeneration Biologic Drug market covered in Chapter 13:
Alimera Sciences
Genentech
Valeant
Acucela
Allergan
Ophthotech Corporation
Bayer
Regeneron
Merck
Eli Lilly
Novartis

In Chapter 6, on the basis of types, the Age Related Macular Degeneration Biologic Drug market from 2015 to 2025 is primarily split into:
Ranibizumab
Bevacizumab
Aflibercept

In Chapter 7, on the basis of applications, the Age Related Macular Degeneration Biologic Drug market from 2015 to 2025 covers:
Outpatient Surgery Center
Eye Clinic
Hospital

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Table of Content

1 Age Related Macular Degeneration Biologic Drug Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Age Related Macular Degeneration Biologic Drug Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Age Related Macular Degeneration Biologic Drug Market Forces
3.1 Global Age Related Macular Degeneration Biologic Drug Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Age Related Macular Degeneration Biologic Drug Market - By Geography
4.1 Global Age Related Macular Degeneration Biologic Drug Market Value and Market Share by Regions
4.1.1 Global Age Related Macular Degeneration Biologic Drug Value ($) by Region (2015-2020)
4.1.2 Global Age Related Macular Degeneration Biologic Drug Value Market Share by Regions (2015-2020)
4.2 Global Age Related Macular Degeneration Biologic Drug Market Production and Market Share by Major Countries
4.2.1 Global Age Related Macular Degeneration Biologic Drug Production by Major Countries (2015-2020)
4.2.2 Global Age Related Macular Degeneration Biologic Drug Production Market Share by Major Countries (2015-2020)
4.3 Global Age Related Macular Degeneration Biologic Drug Market Consumption and Market Share by Regions
4.3.1 Global Age Related Macular Degeneration Biologic Drug Consumption by Regions (2015-2020)
4.3.2 Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Regions (2015-2020)

5 Age Related Macular Degeneration Biologic Drug Market - By Trade Statistics
5.1 Global Age Related Macular Degeneration Biologic Drug Export and Import
5.2 United States Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
5.3 Europe Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
5.4 China Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
5.5 Japan Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
5.6 India Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
5.7 ...

6 Age Related Macular Degeneration Biologic Drug Market - By Type
6.1 Global Age Related Macular Degeneration Biologic Drug Production and Market Share by Types (2015-2020)
6.1.1 Global Age Related Macular Degeneration Biologic Drug Production by Types (2015-2020)
6.1.2 Global Age Related Macular Degeneration Biologic Drug Production Market Share by Types (2015-2020)
6.2 Global Age Related Macular Degeneration Biologic Drug Value and Market Share by Types (2015-2020)
6.2.1 Global Age Related Macular Degeneration Biologic Drug Value by Types (2015-2020)
6.2.2 Global Age Related Macular Degeneration Biologic Drug Value Market Share by Types (2015-2020)
6.3 Global Age Related Macular Degeneration Biologic Drug Production, Price and Growth Rate of Ranibizumab (2015-2020)
6.4 Global Age Related Macular Degeneration Biologic Drug Production, Price and Growth Rate of Bevacizumab (2015-2020)
6.5 Global Age Related Macular Degeneration Biologic Drug Production, Price and Growth Rate of Aflibercept (2015-2020)

7 Age Related Macular Degeneration Biologic Drug Market - By Application
7.1 Global Age Related Macular Degeneration Biologic Drug Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Age Related Macular Degeneration Biologic Drug Consumption by Applications (2015-2020)
7.1.2 Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Applications (2015-2020)
7.2 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Outpatient Surgery Center (2015-2020)
7.3 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Eye Clinic (2015-2020)
7.4 Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate of Hospital (2015-2020)

8 North America Age Related Macular Degeneration Biologic Drug Market
8.1 North America Age Related Macular Degeneration Biologic Drug Market Size
8.2 United States Age Related Macular Degeneration Biologic Drug Market Size
8.3 Canada Age Related Macular Degeneration Biologic Drug Market Size
8.4 Mexico Age Related Macular Degeneration Biologic Drug Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Age Related Macular Degeneration Biologic Drug Market Analysis
9.1 Europe Age Related Macular Degeneration Biologic Drug Market Size
9.2 Germany Age Related Macular Degeneration Biologic Drug Market Size
9.3 United Kingdom Age Related Macular Degeneration Biologic Drug Market Size
9.4 France Age Related Macular Degeneration Biologic Drug Market Size
9.5 Italy Age Related Macular Degeneration Biologic Drug Market Size
9.6 Spain Age Related Macular Degeneration Biologic Drug Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Age Related Macular Degeneration Biologic Drug Market Analysis
10.1 Asia-Pacific Age Related Macular Degeneration Biologic Drug Market Size
10.2 China Age Related Macular Degeneration Biologic Drug Market Size
10.3 Japan Age Related Macular Degeneration Biologic Drug Market Size
10.4 South Korea Age Related Macular Degeneration Biologic Drug Market Size
10.5 Southeast Asia Age Related Macular Degeneration Biologic Drug Market Size
10.6 India Age Related Macular Degeneration Biologic Drug Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Analysis
11.1 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Size
11.2 Saudi Arabia Age Related Macular Degeneration Biologic Drug Market Size
11.3 UAE Age Related Macular Degeneration Biologic Drug Market Size
11.4 South Africa Age Related Macular Degeneration Biologic Drug Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Age Related Macular Degeneration Biologic Drug Market Analysis
12.1 South America Age Related Macular Degeneration Biologic Drug Market Size
12.2 Brazil Age Related Macular Degeneration Biologic Drug Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Alimera Sciences
13.1.1 Alimera Sciences Basic Information
13.1.2 Alimera Sciences Product Profiles, Application and Specification
13.1.3 Alimera Sciences Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.2 Genentech
13.2.1 Genentech Basic Information
13.2.2 Genentech Product Profiles, Application and Specification
13.2.3 Genentech Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.3 Valeant
13.3.1 Valeant Basic Information
13.3.2 Valeant Product Profiles, Application and Specification
13.3.3 Valeant Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.4 Acucela
13.4.1 Acucela Basic Information
13.4.2 Acucela Product Profiles, Application and Specification
13.4.3 Acucela Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.5 Allergan
13.5.1 Allergan Basic Information
13.5.2 Allergan Product Profiles, Application and Specification
13.5.3 Allergan Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.6 Ophthotech Corporation
13.6.1 Ophthotech Corporation Basic Information
13.6.2 Ophthotech Corporation Product Profiles, Application and Specification
13.6.3 Ophthotech Corporation Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.7 Bayer
13.7.1 Bayer Basic Information
13.7.2 Bayer Product Profiles, Application and Specification
13.7.3 Bayer Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.8 Regeneron
13.8.1 Regeneron Basic Information
13.8.2 Regeneron Product Profiles, Application and Specification
13.8.3 Regeneron Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.9 Merck
13.9.1 Merck Basic Information
13.9.2 Merck Product Profiles, Application and Specification
13.9.3 Merck Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.10 Eli Lilly
13.10.1 Eli Lilly Basic Information
13.10.2 Eli Lilly Product Profiles, Application and Specification
13.10.3 Eli Lilly Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)
13.11 Novartis
13.11.1 Novartis Basic Information
13.11.2 Novartis Product Profiles, Application and Specification
13.11.3 Novartis Age Related Macular Degeneration Biologic Drug Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Age Related Macular Degeneration Biologic Drug Market Forecast (2020-2025)
14.2 Europe Age Related Macular Degeneration Biologic Drug Market Forecast (2020-2025)
14.3 Asia-Pacific Age Related Macular Degeneration Biologic Drug Market Forecast (2020-2025)
14.4 Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Forecast (2020-2025)
14.5 South America Age Related Macular Degeneration Biologic Drug Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Age Related Macular Degeneration Biologic Drug Market Forecast by Types (2020-2025)
15.1.1 Global Age Related Macular Degeneration Biologic Drug Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Age Related Macular Degeneration Biologic Drug Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Age Related Macular Degeneration Biologic Drug Market Forecast by Applications (2020-2025)

List of Tables and Figures

Figure Age Related Macular Degeneration Biologic Drug Picture
Table Age Related Macular Degeneration Biologic Drug Key Market Segments
Figure Study and Forecasting Years
Figure Global Age Related Macular Degeneration Biologic Drug Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Age Related Macular Degeneration Biologic Drug Value ($) and Growth Rate (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Value ($) by Countries (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Value Market Share by Regions (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value Market Share by Regions in 2019
Figure Global Age Related Macular Degeneration Biologic Drug Production and Growth Rate (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production by Major Countries (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production Market Share by Major Countries (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Production Market Share by Regions in 2019
Figure Global Age Related Macular Degeneration Biologic Drug Consumption and Growth Rate (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Consumption by Regions (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Regions (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Regions in 2019
Table Global Age Related Macular Degeneration Biologic Drug Export Top 3 Country 2019
Table Global Age Related Macular Degeneration Biologic Drug Import Top 3 Country 2019
Table United States Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
Table China Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
Table Japan Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
Table India Age Related Macular Degeneration Biologic Drug Export and Import (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production by Types (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Production Market Share by Types (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Production Share by Type (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Value by Types (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Value Market Share by Types (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Value Share by Type (2015-2020)
Figure Global Ranibizumab Production and Growth Rate (2015-2020)
Figure Global Ranibizumab Price (2015-2020)
Figure Global Bevacizumab Production and Growth Rate (2015-2020)
Figure Global Bevacizumab Price (2015-2020)
Figure Global Aflibercept Production and Growth Rate (2015-2020)
Figure Global Aflibercept Price (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Consumption by Applications (2015-2020)
Table Global Age Related Macular Degeneration Biologic Drug Consumption Market Share by Applications (2015-2020)
Figure Global Age Related Macular Degeneration Biologic Drug Consumption Share by Application (2015-2020)
Figure Global Outpatient Surgery Center Consumption and Growth Rate (2015-2020)
Figure Global Eye Clinic Consumption and Growth Rate (2015-2020)
Figure Global Hospital Consumption and Growth Rate (2015-2020)
Figure North America Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Consumption by Countries (2015-2020)
Table North America Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure North America Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure United States Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Canada Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Mexico Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Consumption by Countries (2015-2020)
Table Europe Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Europe Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Germany Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure France Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Italy Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Spain Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Age Related Macular Degeneration Biologic Drug Consumption by Countries (2015-2020)
Table Asia-Pacific Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure China Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Japan Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure South Korea Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure India Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Consumption by Countries (2015-2020)
Table Middle East and Africa Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure UAE Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure South Africa Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Figure South America Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Consumption by Countries (2015-2020)
Table South America Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure South America Age Related Macular Degeneration Biologic Drug Consumption Market Share by Countries (2015-2020)
Figure Brazil Age Related Macular Degeneration Biologic Drug Market Consumption and Growth Rate (2015-2020)
Table Alimera Sciences Company Profile
Table Alimera Sciences Production, Value, Price, Gross Margin 2015-2020
Figure Alimera Sciences Production and Growth Rate
Figure Alimera Sciences Value ($) Market Share 2015-2020
Table Genentech Company Profile
Table Genentech Production, Value, Price, Gross Margin 2015-2020
Figure Genentech Production and Growth Rate
Figure Genentech Value ($) Market Share 2015-2020
Table Valeant Company Profile
Table Valeant Production, Value, Price, Gross Margin 2015-2020
Figure Valeant Production and Growth Rate
Figure Valeant Value ($) Market Share 2015-2020
Table Acucela Company Profile
Table Acucela Production, Value, Price, Gross Margin 2015-2020
Figure Acucela Production and Growth Rate
Figure Acucela Value ($) Market Share 2015-2020
Table Allergan Company Profile
Table Allergan Production, Value, Price, Gross Margin 2015-2020
Figure Allergan Production and Growth Rate
Figure Allergan Value ($) Market Share 2015-2020
Table Ophthotech Corporation Company Profile
Table Ophthotech Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Ophthotech Corporation Production and Growth Rate
Figure Ophthotech Corporation Value ($) Market Share 2015-2020
Table Bayer Company Profile
Table Bayer Production, Value, Price, Gross Margin 2015-2020
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2015-2020
Table Regeneron Company Profile
Table Regeneron Production, Value, Price, Gross Margin 2015-2020
Figure Regeneron Production and Growth Rate
Figure Regeneron Value ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2015-2020
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table Eli Lilly Company Profile
Table Eli Lilly Production, Value, Price, Gross Margin 2015-2020
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Production, Value, Price, Gross Margin 2015-2020
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Production by Types (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Production Share by Types (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Value ($) by Types (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Value Share by Types (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Consumption by Applications (2020-2025)
Table Global Age Related Macular Degeneration Biologic Drug Market Forecast Consumption Share by Applications (2020-2025)